A phase III, Multicenter, Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of Oral MK-0974 in the Acute Treatment of Migraine with or Without Aura.

Registry ID

EUCTR2006-006187-35

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

Laboratoires Merck Sharp & Dohme - Chibret

Start date

2007-04-10

Completion date

2008-01-11

Last update

2026-08-16

Conditions

• Acute treatment of Migraine
• Migraine

Summary

- To evaluate the efficacy of MK-0974 (300 mg and 150 mg) compared to placebo in the treatment of acute migraine as measured using pain freedom, pain relief, freedom from photophobia, freedom from phonophobia and freedom from nausea. - To evaluate the safety and tolerability of MK-0974 in the treatment of acute migraine

Locations

• , , France
• , , Austria
• , , Germany

Related clinical trials

• NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
• Emgality for Migraine in Breastmilk
• Study of EVO756 in Adults With Migraine
• Responding With Evidence and Access for Childhood Headaches
• Headache Ear Auditory Dizziness Sinus (HEADS) Registry
• A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

View on source registry